SeraCare

SeraCare Life Sciences is a prominent supplier of diagnostic quality controls, biological materials, and reagents for in vitro diagnostics developers, clinical laboratories, and life science researchers globally. Established in 1984 as Boston Biomedica Inc., the company is headquartered in Milford, Massachusetts, with an additional facility in Gaithersburg, Maryland. SeraCare has been a trusted partner in the diagnostic testing industry for over 30 years and is currently part of LGC, a KKR-backed company. The company offers a range of products, including ACCURUN® controls and reference materials, Seraseq® next-generation sequencing reference materials, customizable biological materials, and reagents for drug and vaccine development. SeraCare focuses on the evaluation and quality control of infectious disease tests and has a strong presence in the clinical next-generation sequencing market. Its customers include pharmaceutical companies, clinical laboratories, and in vitro diagnostics manufacturers, with sales primarily in the United States, Europe, and Asia. SeraCare operates ISO 13485-certified facilities and adheres to cGMP standards.